Wrap Text
ASPI announces Quantum Leap Energy is evaluating metal conversion opportunities in Namibia
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
ASPI ANNOUNCES QUANTUM LEAP ENERGY IS EVALUATING METAL CONVERSION OPPORTUNITIES IN NAMIBIA
DALLAS, August 18, 2026 – ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum
Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to
advancing innovative technologies and processes across critical segments of the fission and fusion nuclear
fuel cycle, is evaluating metal conversion opportunities in Namibia.
As part of this evaluation, a public environmental and social impact assessment and consultation process
has commenced for a proposed pilot-scale hydrofluorination and fluorination facility in the Walvis Bay area
of Namibia. The proposed facility would be used to develop, test and demonstrate hydrofluorination and
fluorination processes for metals.
In accordance with Namibian regulatory requirements, public consultation notices have been published
through customary local channels, including in the Republikein, Allgemeine Zeitung, and The Namibian
newspapers.
The evaluation remains at an early stage, and no final investment decision has been made. Any future
development would be subject to technical, commercial, environmental and regulatory review and
approvals.
About Quantum Leap Energy
Quantum Leap Energy is a development stage nuclear fuels company dedicated to advancing innovative
technologies and processes across critical segments of the nuclear fuel cycle. The company focuses on
uranium conversion, enrichment of uranium-235 for nuclear fuel production (HALEU, LEU+ and LEU), and
isotopic separation of lithium-6 and lithium-7, as well as radioactive waste treatment technologies. Through
exclusive global rights to proprietary Aerodynamic Separation Process (ASP) and laser-based Quantum
Enrichment (QE) technologies, Quantum Leap Energy aims to address perceived gaps in the nuclear fuel
supply chain for advanced nuclear reactors, small modular reactors, and fusion systems. The company has
established strategic partnerships or commercial initiatives and relationships with industry leaders including
TerraPower, Fermi America, and the South Africa Nuclear Energy Corporation (Necsa) to accelerate the
commercialization of critical isotopes essential for next-generation nuclear energy systems. *The company
has not applied its enrichment technologies to the enrichment of U-235, nor received permission or
regulatory approval to conduct testing of our enrichment technologies on U-235, except for the activities
contemplated by the services contract with Necsa. For additional information, please visit:
https://www.qleapenergy.com/.
About ASP Isotopes Inc.
ASP Isotopes is an advanced materials company dedicated to the development of a differentiated isotope
enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine,
next-generation semiconductors, and nuclear energy. The Company’s proprietary technologies, the
Aerodynamic Separation Process (“ASP technology”) and Quantum Enrichment (“QE technology”), are
designed to enable the production of isotopes for a range of industrial and advanced technology
applications. ASP Isotopes operates isotope enrichment facilities in Pretoria, South Africa, focused on the
enrichment of low atomic mass elements, or light isotopes. For more information, please
visit www.aspisotopes.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions
of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither
historical facts nor assurances of future performance. Instead, they are based only on ASPI’s current
beliefs, expectations, and assumptions regarding the future of its business, as well as the business of its
subsidiaries, including, without limitation, QLE, future plans and strategies, projections, anticipated events
and trends, the economy, and other future conditions. Forward-looking statements can be identified by
words such as “believes,” “plans,” “anticipates,” “expects,” “estimates,” “projects,” “will,” “may,” “might,” and
words of a similar nature. Examples of forward-looking statements include, but are not limited to, statements
we make regarding a potential pilot-scale hydrofluorination and fluorination facility in Namibia. Because
forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and
changes in circumstances that are difficult to predict, many of which are outside our control. Actual results,
financial condition, and events may differ materially from those indicated in the forward-looking statements
based upon a number of factors. Forward-looking statements are not a guarantee of future performance or
developments. You are strongly cautioned that reliance on any forward-looking statements involves known
and unknown risks and uncertainties. Therefore, you should not rely on any of these forward-looking
statements. There are many important factors that could cause actual results and financial condition to
differ materially from those indicated in the forward-looking statements, including, but not limited to: the
outcomes of various strategies and projects undertaken by ASPI and QLE; the potential impact of laws or
government regulations or policies in South Africa, the United Kingdom or elsewhere; QLE’s future capital
requirements and sources and uses of cash; QLE’s ability to obtain funding for its operations and future
growth; QLE’s reliance on the efforts of third parties; QLE’s ability to complete the construction and
commissioning of its enrichment plants or to commercialize isotopes using the ASP technology or the
Quantum Enrichment Process; QLE’s ability to obtain regulatory approvals for the production and
distribution of isotopes; the financial terms of any current and future commercial arrangements; QLE’s ability
to complete certain transactions and realize anticipated benefits from acquisitions and contracts;
dependence on QLE’s Intellectual Property (IP) rights, certain IP rights of third parties; the competitive
nature of QLE’s industry; and the factors disclosed in Part I, Item 1A. “Risk Factors” of ASPI’s Annual Report
on Form 10-K for the fiscal year ended December 31, 2025 (as amended) and in ASPI’s subsequent reports
and filings with the SEC. Any forward-looking statement made by us in this press release is based only on
information currently available to us and speaks only as of the date on which it is made. We undertake no
obligation to publicly update any forward-looking statement, whether as a result of new information, future
developments or otherwise. No information in this press release should be interpreted as an indication of
future success, revenues, results of operation, or stock price. All forward-looking statements herein are
qualified by reference to the cautionary statements set forth herein and should not be relied upon.
QLE Contact
QLE@icrinc.com
ASPI Contact
IR@ASPIsotopes.com
The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.
18 August 2026
Sponsor
Valeo Capital Proprietary Limited
Date: 18/08/2026 12:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
